Source: FinanzNachrichten

Proteros: EQS-News: Proteros biostructures GmbH: Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

EQS-News: Proteros biostructures GmbH / Key word(s): Alliance Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases 25.10.2022 /...

Read full article »
Proteros's Competitors | Proteros's News | Proteros's Financials
Stay up-to-date with the latest news on Proteros
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Torsten Neuefeind's photo - Co-Founder & CEO of Proteros

Co-Founder & CEO

Torsten Neuefeind

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Proteros